Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-03T05:00:22.732Z Has data issue: false hasContentIssue false
  • English
  • Français

Orbital decompression surgery for thyroid eye disease: implications for anaesthesia

Published online by Cambridge University Press:  24 January 2006

L. Stannard ,
R. M. Slater  and
B. Leatherbarrow
L. Stannard
Affiliation:
Manchester Royal Infirmary, Department of Anaesthetics, Manchester, UK
R. M. Slater
Affiliation:
Manchester Royal Infirmary, Department of Anaesthetics, Manchester, UK
B. Leatherbarrow
Affiliation:
Manchester Royal Eye Hospital, Department of Ophthalmology, Manchester, UK
Get access

Extract

Summary

The management of thyroid-associated eye disease is reviewed with particular reference to surgical management and its implications for anaesthetists. Experience from a unit undertaking such surgery is presented.

Keywords

ANAESTHESIA, GENERALGRAVES' DISEASETHYROID DISEASESEXOPHTHALMOSSURGICAL PROCEDURES, OPERATIVE
Type
Review
Information
European Journal of Anaesthesiology , Volume 23 , Issue 3 , March 2006 , pp. 183 - 189
Copyright
© 2006 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Farling PA. Thyroid disease. Br J Anaesth 2000; 85: 15–28.Google Scholar
Weetman AP. Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338: 25–28.Google Scholar
Tunbridge WMG, Everend DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 1977; 7: 481–493.Google Scholar
Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endoc Rev 1984; 5: 200–220.Google Scholar
van der Wal KGH, de Visscher JGAM, Boukes RJ, Smeding B. Surgical treatment of Graves orbitopathy: a modified balanced technique. Int J Oral Maxillofac Surg 2001; 30: 254–258.Google Scholar
Marcocci C, Bartalena L, Bogazzi F, Panicucci M, Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol 1989; 120: 473–478.Google Scholar
Perros P, Crombie AL, Matthews JNS, Kendall-Taylor P. Age and gender influence the severity of thyroid-associated ophthalmopathy: A study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol 1993; 38: 367–372.Google Scholar
Bartley GB, Fatourechi V, Kadrmas EF et al. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmology 1995; 120: 511–517.Google Scholar
Atabay C, Tyutyunikov A, Scalise D. Serum antibodies reactive with eye muscle membrane antigens are detected in patients with non-specific orbital inflammation. Ophthalmology 1995; 102: 145–153.Google Scholar
Prummel MF, Suttorp SM, Wiersinga WM, Verbeck AM, Mourits MP, Koornneef L. A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves' ophthalmopathy. Ophthalmology 1993; 100: 556–561.Google Scholar
Weetman AP, Cohen S, Gatter KC, Fells P, Shine B. Immunohistochemical analysis of the retro-bulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol 1989; 75: 222–227.Google Scholar
Rundle FF, Wilson CW. Development and course of exophthalmos and ophthalmoplegia in Graves' disease with special reference to the effect of thyroidectomy. Clin Science 1945; 5: 177–194.Google Scholar
Solomon DH, Chopra IJ, Chopra U, Smith FJ. Identification of subgroups of euthyroid Graves' ophthalmopathy. New Engl J Med 1977; 296: 181–185.Google Scholar
Lazarus JH. Relation Between Thyroid Eye Disease and Type of Treatment of Graves' Hyperthyroidism. Thyroid 1998; 8: 437.Google Scholar
Carey C, Skosey C, Pimmananeni KM, Barsona CP, DeGroot L. Thyroid abnormalities in children of parents who have Graves' disease: possible pre-Graves' disease. Metabolism 1980; 29: 369–376.Google Scholar
Villanueva R, Inzerillo AM, Tomer Y et al. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Thyroid 2000; 10: 791–798.Google Scholar
Hadden DR, McDevitt A. Environmental stress and thyrotoxicosis: absence of an association. Lancet 1974; 2: 577–578.Google Scholar
Winsa B, Adamii HO, Bergstrom R. Stessful life events and Graves' disease. Lancet 1991; 338: 1475–1479.Google Scholar
Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993; 269: 479–482.Google Scholar
Pfeilschifter J, Ziegler R. Smoking and endocrine ophthalmopathy: Impact of smoking severity and current vs. lifetime cigarette consumption. Clin Endocrinol 1996; 45: 477–481.Google Scholar
Mann K. Risk of smoking in thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 1999; 107: 164–167.Google Scholar
Tallstedt L, Lundel G, Taube A. Graves' ophthalmopathy and tobacco smoking. Acta Endocrinol 1993; 129: 147–150.Google Scholar
Anonymous. Classification of eye changes of Graves' disease. Thyroid 1992; 2: 235–236.
Utech CI, Khatibnia U, Winter PF, Wulle KG. MR T2 relaxation time for the assessment of retro-bulbar inflammation in Graves' ophthalmopathy. Thyroid 1995; 5: 185–193.Google Scholar
Bailey CC, Kabala J, Laitt R et al. Magnetic resonance imaging in thyroid eye disease. Eye 1996; 10: 617–619.Google Scholar
Neigel JM, Rootman J, Belkin RI et al. Dysthyroid optic neuropathy: The crowded orbital apex syndrome. Ophthal-mology 1988; 95: 1515–1521.Google Scholar
Kendler DL, Lippa J, Rootman J. The initial clinical characteristic of Graves' orbitopathy vary with age and sex. Arch Ophthal 1993; 111: 197–201.Google Scholar
Perros P, Kendall-Taylor P. Medical Treatment for Thyroid-Associated Ophthalmopathy. Thyroid 2002; 12: 241–244.Google Scholar
Burch HB, Wartofsky L. Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747–793.Google Scholar
Claridge KG, Ghabrial R, Davis G et al. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease. Eye 1997; 11: 717–722.Google Scholar
Werner SC. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1966; 1: 10004–10007.Google Scholar
Kendall-Taylor P, Crombie AL, Stephenson AM, Hardwick M, Hall K. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. Br Med J 1988; 297: 1574–1578.Google Scholar
Bartelena L, Marcocci C, Chiovato L et al. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: Comparison with systemic corticosteroids alone. J Clin Endocrinol Metab 1983; 56: 1139–1144.Google Scholar
McCord CD. Current trends in orbital decompression. Ophthalmology 1985; 92: 21–31.Google Scholar
Leone CR, Piest KL, Newman RJ. Medial and lateral wall decompression for thyroid ophthalmopathy. Am J Ophthalmol 1989; 108: 160–166.Google Scholar
Fatourechi V, Garrity JA, Bartley GB. Graves' ophthalmopathy: results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology 1994; 101: 938–942.Google Scholar
Garrity JA, Fatourechi V, Bergstralh EJ et al. Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathy. Am J Ophthalmol 1993; 116: 533–547.Google Scholar
Shorr N, Neuhaus RW, Baylis HI. Ocular motility problems after orbital decompression for dysthyroid ophthalmopathy. Ophthalmology 1982; 89: 323–328.Google Scholar
Mourits MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Orbital decompression for TAO by inferomedial, by inferomedial plus lateral, and by coronal approach. Ophthalmology 1990; 97: 636–641.Google Scholar
Hutchinson BM, Kyle PM. Long-term visual outcome following orbital decompression for dysthyroid eye disease. Eye 1995; 9: 578–581.Google Scholar
Tallstedt L, Papatziamos G, Lundblad L, Anggard A. Results of transantral orbital decompression in patients with thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 2000; 78: 206–210.Google Scholar
McNab AA. Orbital decompression for thyroid orbitopathy. Aust N Z J Ophthalmol 1997; 25: 55–67.Google Scholar
Paridaens D, Hans K, van Buitenen S, Mourits MP. The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy. Eye 1998; 12: 800–805.Google Scholar
Linnet J, Hegedus L, Bjerre P. Results of a neurosurgical two-wall orbital decompression in the treatment of severe thyroid associated ophthalmopathy. Acta Ophthalmol Scand 2001; 79: 49–52.Google Scholar
Michel O, Oberlander N, Neugebauer P, Neugebauer A, Rubmann W. Follow-up of transnasal orbital decompression in severe Graves' ophthalmopathy. Ophthalmology 2001; 108: 400–404.Google Scholar
Goldberg RA, Weinberg DA, Shorr N, Wirta D. Maximal, three-wall, orbital decompression through a coronal approach. Ophthalmic Surg Lasers 1997; 28: 832–843.Google Scholar